Thomas H Aasen Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas H Aasen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas H Aasen. Thomas H Aasen is EXEC VP, CFO AND CBO in ACADIA PHARMACEUTICALS INC ($ACAD).
Latest Insider Trading Transactions of Thomas H Aasen
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | M | 1.55 | 15,000 | 23,250 | 58,708 | |
Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | M | 1.55 | 30,000 | 46,500 | 82,263 | |
Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Sell | S | 20.15 | 60,000 | 1,209,180 | 0 | 60 K to 0 (-100.00 %) |
Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Gift | G | 0.00 | 60,000 | 0 | 60,000 | 0 to 60 K |
Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Gift | G | 0.00 | 60,000 | 0 | 31,585 | 91.6 K to 31.6 K (-65.51 %) |
Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Buy | M | 1.55 | 15,000 | 23,250 | 91,585 | 76.6 K to 91.6 K (+19.59 %) |
Aug 15 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Buy | M | 1.55 | 30,000 | 46,500 | 76,585 | 46.6 K to 76.6 K (+64.40 %) |
Jun 11 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | A | 17.01 | 175,000 | 2,976,750 | 175,000 | |
Apr 12 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | M | 1.55 | 14,029 | 21,745 | 73,708 | |
Apr 12 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | M | 2.00 | 12,500 | 25,000 | 0 | |
Apr 12 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | M | 1.08 | 7,500 | 8,100 | 0 | |
Apr 12 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Sell | S | 11.06 | 40,000 | 442,400 | 0 | 40 K to 0 (-100.00 %) |
Apr 12 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Gift | G | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
Apr 12 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Gift | G | 0.00 | 40,000 | 0 | 44,500 | 84.5 K to 44.5 K (-47.34 %) |
Apr 12 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Buy | M | 1.55 | 14,029 | 21,745 | 84,500 | 70.5 K to 84.5 K (+19.91 %) |
Apr 12 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Buy | M | 2.00 | 12,500 | 25,000 | 70,471 | 58 K to 70.5 K (+21.56 %) |
Apr 12 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Buy | M | 1.08 | 7,500 | 8,100 | 57,971 | 50.5 K to 58 K (+14.86 %) |
Apr 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | M | 1.08 | 36,490 | 39,409 | 7,500 | |
Apr 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | M | 1.08 | 3,510 | 3,791 | 0 | |
Apr 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Sell | S | 7.68 | 40,000 | 307,084 | 0 | 40 K to 0 (-100.00 %) |
Apr 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Gift | G | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
Apr 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Gift | G | 0.00 | 40,000 | 0 | 50,471 | 90.5 K to 50.5 K (-44.21 %) |
Apr 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Buy | M | 1.08 | 36,490 | 39,409 | 90,471 | 54 K to 90.5 K (+67.60 %) |
Apr 03 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Buy | M | 1.08 | 3,510 | 3,791 | 53,981 | 50.5 K to 54 K (+6.95 %) |
Jan 18 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | M | 1.08 | 12,000 | 12,960 | 43,990 | |
Jan 18 2013 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Buy | M | 1.08 | 12,000 | 12,960 | 50,471 | 38.5 K to 50.5 K (+31.19 %) |
Nov 29 2012 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | M | 1.08 | 5,000 | 5,400 | 3,510 | |
Nov 29 2012 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Sell | S | 5.25 | 9,100 | 47,774 | 0 | 9.1 K to 0 (-100.00 %) |
Nov 29 2012 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Gift | G | 0.00 | 5,000 | 0 | 9,100 | 4.1 K to 9.1 K (+121.95 %) |
Nov 29 2012 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Gift | G | 0.00 | 5,000 | 0 | 28,471 | 33.5 K to 28.5 K (-14.94 %) |
Nov 29 2012 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Buy | M | 1.08 | 5,000 | 5,400 | 33,471 | 28.5 K to 33.5 K (+17.56 %) |
Nov 29 2012 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Sell | S | 6.24 | 30,900 | 192,859 | 4,100 | 35 K to 4.1 K (-88.29 %) |
Nov 29 2012 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Gift | G | 0.00 | 33,631 | 0 | 35,000 | 1.4 K to 35 K (+2,456.61 %) |
Nov 29 2012 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Gift | G | 0.00 | 33,631 | 0 | 28,471 | 62.1 K to 28.5 K (-54.15 %) |
Sep 11 2012 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | M | 1.50 | 7,500 | 11,250 | 20,000 | |
Sep 11 2012 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Buy | M | 1.50 | 7,500 | 11,250 | 62,102 | 54.6 K to 62.1 K (+13.74 %) |
Aug 06 2012 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | M | 1.50 | 5,000 | 7,500 | 27,500 | |
Aug 06 2012 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Buy | M | 1.50 | 5,000 | 7,500 | 54,602 | 49.6 K to 54.6 K (+10.08 %) |
Mar 26 2012 | ACAD | ACADIA PHARMACEUTI ... | Aasen Thomas H | EXEC VP, CFO AND CB ... | Option Exercise | A | 1.18 | 175,000 | 206,500 | 175,000 |
Page: 1